Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Thiophene pyrimidine >  4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINE

4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINE

Basic information Safety Supplier Related

4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINE Basic information

Product Name:
4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINE
Synonyms:
  • 4-Chloro-7-methylthieno[3,2-d]pyrimidine 97%
  • 4-Chloro-7-Methylthieno[3...
  • 4-Chloro-7-methylthieno[3,2-d]pyrimidine97%
  • BUTTPARK 46\18-89
  • 4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINE
  • 4-Chloro-7-methylthieno[2,3-d]pyrimidine
  • 7-CHLORO-3-METHYLTHIENO(3,2-D)PYRIMIDINE
  • Thieno[3,2-d]pyrimidine,4-chloro-7-methyl-
CAS:
175137-21-0
MF:
C7H5ClN2S
MW:
184.65
Mol File:
175137-21-0.mol
More
Less

4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINE Chemical Properties

Melting point:
124 °C
Boiling point:
301.3±37.0 °C(Predicted)
Density 
1.445±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
pka
0.78±0.40(Predicted)
Appearance
Off-white to light yellow Solid
InChI
InChI=1S/C7H5ClN2S/c1-4-2-11-6-5(4)9-3-10-7(6)8/h2-3H,1H3
InChIKey
IYJDOVYAFDVIDB-UHFFFAOYSA-N
SMILES
C1=NC(Cl)=C2SC=C(C)C2=N1
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36
Safety Statements 
26
Hazard Note 
Irritant
HS Code 
2934999090
More
Less

4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINE Usage And Synthesis

Synthesis

175137-13-0

175137-21-0

General procedure for the synthesis of 4-chloro-7-methylthieno[3,2-d]pyrimidin-4(1H)-one from 7-methylthieno[3,2-d]pyrimidin-4-one: 7-methyl-3H-thieno[3,2-d]pyrimidin-4-one (167, 10.6 g, 64.0 mmol) was dissolved in phosphorus nitrogen oxide (42 mL), and the reaction was carried out for 2 h under nitrogen protection at reflux. Upon completion of the reaction, the reaction solution was cooled to room temperature and slowly poured into saturated aqueous sodium carbonate solution (300 mL) for neutralization. Subsequently, the aqueous phase was extracted with ethyl acetate, and the organic layers were combined, washed with water and saturated brine sequentially, and then dried with anhydrous magnesium sulfate. The organic solvent was removed by concentration under reduced pressure and the resulting residue was dried under vacuum overnight in the presence of phosphorus pentoxide to afford the white solid product 4-chloro-7-methylthieno[3,2-d]pyrimidine (168, 11.2 g, 95% yield).

References

[1] Patent: US2006/4002, 2006, A1. Location in patent: Page/Page column 12; 21; 23; 30; 31-32
[2] Patent: WO2013/100632, 2013, A1. Location in patent: Page/Page column 62
[3] Patent: US2014/371219, 2014, A1. Location in patent: Paragraph 0436; 0437
[4] Patent: WO2012/156756, 2012, A2. Location in patent: Page/Page column 99
[5] Patent: WO2011/93684, 2011, A2. Location in patent: Page/Page column 33; 34

4-CHLORO-7-METHYLTHIENO[3,2-D]PYRIMIDINESupplier

Nanjing Chalf-Pharm Technology Co., Ltd. Gold
Tel
025-57018978 18251899859
Email
sales@chalf-pharm.com
Changzhou ruiqing medical technology co., LTD Gold
Tel
0519-85859396 15380475813
Email
656870630@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Wuhan Chemwish Technology Co., Ltd
Tel
86-027-67849912
Email
sales@chemwish.com
Shanghai Sinch Parmaceuticals Tech. Co. Ltd.
Tel
+86-21-54098501
Email
sales@sinch.com.cn